Grace Therapeutics, Inc.

GRCE · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$16,862$20,005$22,133$11,055
Short-Term Investments$0$0$0$0
Receivables$20$20$126$301
Inventory$0$0$0$0
Other Curr. Assets$416$500$453$583
Total Curr. Assets$17,298$20,525$22,712$11,939
Property Plant & Equip (Net)$12$14$15$19
Goodwill$8,138$8,138$8,138$8,138
Intangibles$41,128$41,128$41,128$41,128
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$0$0
Total NC Assets$49,278$49,280$49,281$49,285
Other Assets$0$0$0$0
Total Assets$66,576$69,805$71,993$61,224
Liabilities
Payables$459$1,339$601$665
Short-Term Debt$0$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$786$976$1,329$1,306
Total Curr. Liab.$1,245$2,315$1,930$1,971
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$2,312$2,312$2,312$3,333
Other NC Liab.$201$1,628$1,141$3,781
Total NC Liab.$2,513$3,940$3,453$7,114
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$3,758$6,255$5,383$9,085
Equity
Pref Stock$0$0$0$0
Common Stock$1$1$1$1
Retained Earnings-$224,987-$224,049-$220,687-$221,323
AOCI-$6,038-$6,038-$6,038-$6,038
Other Equity$293,842$293,636$293,334$279,499
Total Equity$62,818$63,550$66,610$52,139
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$66,576$69,805$71,993$61,224
Net Debt-$16,862-$20,005-$22,133-$11,055
Grace Therapeutics, Inc. (GRCE) Financial Statements & Key Stats | AlphaPilot